CureVac
CVAC
CVAC was delisted on the 5th of January, 2026.
75 hedge funds and large institutions have $26.6M invested in CureVac in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 25 reducing their positions, and 17 closing their positions.
12% more call options, than puts
Call options by funds: $322K | Put options by funds: $288K
1.46% less ownership
Funds ownership: 4.96% → 3.5% (-1.5%)
7% less funds holding
Funds holding: 81 → 75 (-6)
19% less capital invested
Capital invested by funds: $32.8M → $26.6M (-$6.2M)
20% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 25
29% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 17
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.49M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$495K |
| 3 |
Two Sigma Investments
New York
|
+$331K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$288K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$152K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$2.92M |
| 2 |
Millennium Management
New York
|
-$2.22M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$979K |
| 4 |
BlackRock
New York
|
-$408K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$333K |
CVAC Hedge Fund Activity: Q4 2024 in Review
75 institutional investors reported a position in CureVac (CVAC) for Q4 2024, worth a combined $26.6M — down 19% from $32.8M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of CVAC and 12 opened new positions — a net loss of 5 holders — while 25 trimmed existing stakes and 20 added.
The largest buyer was UBS Group, adding an estimated $1.49M. The largest seller was Citadel Advisors, exiting entirely with an estimated $2.92M sold.
- 75 institutional investors held CureVac (CVAC) as of Q4 2024, down from 81 in Q3 2024.
- Funds reported $26.6M of CureVac stock for Q4 2024, down 19% quarter-over-quarter.
- 12 funds opened new CureVac positions in Q4 2024 and 17 closed out, a net change of -5 holders.
- The largest CureVac buyer in Q4 2024 was UBS Group, an estimated $1.49M added.
- The largest CureVac seller in Q4 2024 was Citadel Advisors, an estimated $2.92M sold.
Based on aggregated 13F filings for Q4 2024.